Lilly stopped the export of non-essential drugs and will only supply medicines for urgent medical ailments to Russia. Credit: Momoneymoproblemz / Wikimedia.

Understand the impact of the Ukraine conflict from a cross-sector perspective with the Global Data Executive Briefing: Ukraine Conflict

Eli Lilly and Company has suspended all investments and promotional works in Russia and will only deliver medicines for urgent medical ailments such as cancer and diabetes amid the Ukraine crisis.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company also halted new clinical trials and the exporting of non-essential medicines to Russia. 

On generating profits from the continued sales of essential drugs in Russia, Lilly intends to donate them to the organisations that provide humanitarian relief.

In a statement, the company said: “Our Russian operations are now only focused on ensuring people suffering from diseases like cancer and diabetes continue to get the Lilly medicines they need. 

“We have an ethical and moral obligation to help alleviate human suffering and to protect the lives of patients.”

Apart from the donations of lifesaving therapies, the tax-exempt organisation of the company Lilly Foundation is extending contributions worth $500,000.

The Lilly Foundation is also providing a $500,000 donation in two equal parts to Direct Relief and Americares to aid in their respective relief operations in Ukraine.

Furthermore, Lilly is contributing insulin worth $7.5m to a US non-profit organisation (NGO) called Project HOPE that aids healthcare professionals to tackle the world’s greatest health crises. 

At present, the NGO is operating in Ukraine and neighbouring nations, actively providing essential drugs and medical supplies for the people of Ukraine.

The company is also aiding in the delivery of $1.8m worth baricitinib to another US NGO, Direct Relief, which focuses on gathering essential therapies, supplies, equipment and various other crucial emergency relief works. 

Baricitinib is a therapy intended to treat complications arising due to Covid-19 infection.